Learn More
Medchemexpress LLC JNJ-42041935 | 1193383-09-3 | 99.8% | 100 MG

Supplier: Medchemexpress LLC HY12832100MG
JNJ-42041935 is described as a potent, competitive, and selective inhibitor of prolyl hydroxylase (PHD), demonstrating inhibition of PHD1, PHD2, and PHD3 with specific pKi values. It has been investigated for its efficacy in reversing inflammation-induced anemia in rat models and for increasing reticulocytes, hemoglobin, and hematocrit in vivo.
- Potent inhibition of specific enzymes.
- Competitive and selective mode of action.
- Effective in reversing anemia in preclinical models.
- Increases red blood cell precursors, hemoglobin, and hematocrit in animal studies.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.